Targeting nuclear factor erythroid 2-related factor 2-regulated ferroptosis to treat nervous system diseases  

作　　者：Ye-Qi Huang Zheng-Wei Huang Xue-Juan Zhang 

机构地区：[1]College of Pharmacy,Jinan University,Guangzhou 510006,Guangdong Province,China

出　　处：《World Journal of Clinical Cases》2024年第33期6655-6659,共5页世界临床病例杂志（英文）

基　　金：Supported by The Guangdong Basic and Applied Basic Research Foundation,China,No.2024A1515011236.

摘　　要：By critically examining the work,we conducted a comprehensive bibliometric analysis on the role of nuclear factor erythroid 2-related factor 2(NRF2)in nervous system diseases.We also proposed suggestions for future bibliometric studies,including the integration of multiple websites,analytical tools,and analytical approaches,The findings presented provide compelling evidence that ferroptosis is closely associated with the therapeutic challenges of nervous system diseases.Targeted modulation of NRF2 to regulate ferroptosis holds substantial potential for effectively treating these diseases.Future NRF2-related research should not only focus on discovering new drugs but also on designing rational drug delivery systems.In particular,nanocarriers offer substantial potential for facilitating the clinical translation of NRF2 research and addressing existing issues related to NRF2-related drugs.

关 键 词：BIBLIOMETRIC Nervous system diseases Nuclear factor erythroid 2-related factor 2 Ferroptosis TARGET 

分 类 号：R741[医药卫生—神经病学与精神病学]